die('
Site is under construction
Dear site users
Site is under construction.
The site will be ready in less than 24 hours.
We are sorry for the inconvenience.
www.yektaweb.com
');
Reports of Biochemistry and Molecular Biology
rbmb.net
Basic Sciences
http://rbmb.net
1
admin
2322-3480
2322-3480
10.61882/rbmb
en
jalali
1400
10
1
gregorian
2022
1
1
10
4
online
1
fulltext
en
The Impacts of Prepared Plasma-Activated Medium (PAM) Combined with Doxorubicin on the Viability of MCF-7 Breast Cancer Cells: A New Cancer Treatment Strategy
بیوشیمی
Biochemistry
مقالات اصلی
Original Article
<div style="text-align: justify;"><strong><em>Background:</em></strong> For many years, the chemotherapeutic agent doxorubicin (DOX) has been used to treat various cancers; however, DOX initiates several critical adverse effects. Many studies have reported that non-thermal atmospheric pressure plasma can provide novel, but challenging, treatment strategies for cancer patients. To date, tissues and cells have been treated with plasma-activated medium (PAM) as a practical therapy. Consequently, due to the harmful adverse effects of DOX, we were motivated to elucidate the impact of PAM in the presence of DOX on MCF-7 cell proliferation.<br>
<br>
<strong><em>Methods:</em></strong> MTT assay, N-acetyl-L-cysteine (NAC) assay, and flow cytometry analysis were utilized in this research. <br>
<br>
<strong><em>Results:</em></strong> The results demonstrated that 0.45 μM DOX combined with 3-min PAM significantly induced apoptosis (p< 0.01) through intracellular ROS generation in MCF-7 when compared with 0.45 μM DOX alone or 3-min PAM alone. In contrast, after treatment with 0.45 μM DOX plus 4-min PAM, cell necrosis was increased. Hence, DOX combined with 4-min PAM has cytotoxic effects with different mechanisms than 4-min PAM alone, in which the number of apoptotic cells increases.<br>
<br>
<strong><em>Conclusions:</em></strong> Although further investigations are crucial, low doses of DOX plus 3-min PAM could be a promising strategy for cancer therapy. The findings from this research may offer advantageous and innovative clinical strategies for cancer therapy using PAM.</div>
<em><span dir="RTL"></span></em>
Apoptosis, Breast cancer lymphedema, Doxorubicin, Plasma-activated medium (PAM), Necrosis.
640
652
http://rbmb.net/browse.php?a_code=A-10-763-1&slc_lang=en&sid=1
Setareh
Zahedian
100319475328460012459
100319475328460012459
No
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Azadeh
Hekmat
hekmat@ut.ac.ir.
100319475328460012460
100319475328460012460
Yes
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Saeed
Hesami Tackallou
100319475328460012461
100319475328460012461
No
Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran.
Mahmood
Ghoranneviss
100319475328460012462
100319475328460012462
No
Department of Plasma Physics Research Center, Science and Research Branch, Islamic Azad University, Tehran, Iran.